Song Kim - EyeGene Assistant Managing Director
| 185490 Stock | KRW 2,830 15.00 0.53% |
Managing Director
Song Kim is Assistant Managing Director of EyeGene
| Age | 44 |
| Phone | 82 2 322 1687 |
| Web | http://www.eyegene.co.kr |
EyeGene Management Efficiency
The company has return on total asset (ROA) of (0.19) % which means that it has lost $0.19 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (51.1998) %, meaning that it generated substantial loss on money invested by shareholders. EyeGene's management efficiency ratios could be used to measure how well EyeGene manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 7 records | MANAGING DIRECTOR Age | ||
| Min Sung | Stic Investments | N/A | |
| TaeJun Eom | SV Investment | N/A | |
| TakKun Oh | SV Investment | N/A | |
| SungQue Koh | Stic Investments | N/A | |
| Hugh Shin | Stic Investments | N/A | |
| De Park | Stic Investments | N/A | |
| Chang Kim | Stic Investments | N/A | |
Management Performance
| Return On Equity | -51.2 | |||
| Return On Asset | -0.19 |
EyeGene Leadership Team
Elected by the shareholders, the EyeGene's board of directors comprises two types of representatives: EyeGene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EyeGene. The board's role is to monitor EyeGene's management team and ensure that shareholders' interests are well served. EyeGene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EyeGene's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Song Kim, Assistant Managing Director | ||
| Jin Jang, Assistant Managing Director | ||
| Myeong Lee, Assistant Managing Director | ||
| WonIl Yoo, Chief Pres | ||
| YangJe Cho, CoFounder Officer | ||
| Won Yoo, President, Chief Executive Officer, Director | ||
| Du Kim, Director | ||
| Soobeom Lee, Chief Officer | ||
| Jong Choi, Internal Auditor | ||
| Wan Cho, Director |
EyeGene Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EyeGene a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -51.2 | |||
| Return On Asset | -0.19 | |||
| Operating Margin | (3.95) % | |||
| Current Valuation | 576.45 B | |||
| Shares Outstanding | 10.99 M | |||
| Shares Owned By Insiders | 9.70 % | |||
| Shares Owned By Institutions | 0.30 % | |||
| Price To Sales | 66.02 X | |||
| Revenue | 3.24 B | |||
| Gross Profit | 1.54 B |
Pair Trading with EyeGene
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EyeGene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EyeGene will appreciate offsetting losses from the drop in the long position's value.Moving against EyeGene Stock
| 0.7 | 226950 | OliX PharmaceuticalsInc | PairCorr |
| 0.58 | 105560 | KB Financial Group | PairCorr |
| 0.42 | 047810 | Korea Aerospace Indu | PairCorr |
| 0.31 | 298380 | ABL Bio | PairCorr |
The ability to find closely correlated positions to EyeGene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EyeGene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EyeGene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EyeGene to buy it.
The correlation of EyeGene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EyeGene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EyeGene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EyeGene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in EyeGene Stock
EyeGene financial ratios help investors to determine whether EyeGene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EyeGene with respect to the benefits of owning EyeGene security.